Contract analysis

I. EXECUTIVE SUMMARY This memorandum presents a standalone legal analysis of three discrete compliance issues arising from the relationship between Arbor Health Technologies Inc. ("AHT") and Pinnacle Laboratory Services Inc. ("Pinnacle") under the Federal Anti-Kickback Statute, 42 U.S.C. § 1320a-7b (the "AKS"), and the Federal Physician Self-Referral Law, 42 U.S.C. § 1395nn (the "Stark Law"). This memorandum has been

1. No-Cost Electronic Laboratory Interface ("LabLink Interface"). Pinnacle provides a proprietary electronic laboratory ordering and results interface integrated into AHT's ArborConnect electronic health record ("EHR") platform at zero cost to AHT, under the preferred laboratory agreement dated June 15, 2020. The estimated fair market value of this interface is approximately $120,000 per year, based on comparable Saa

2. Continuing Medical Education ("CME") Sponsorship. Pinnacle sponsored four CME events for AHT physicians in fiscal year 2022, with an aggregate sponsorship value of $86,000. The events covered clinical laboratory topics and were attended by AHT physicians who are sources of referrals to Pinnacle for clinical laboratory services.

3. Dr. Karen Ellsworth's Equity Interest. Dr. Karen Ellsworth, an independent physician and the spouse of Dr. Nathan Ellsworth (Chief Executive Officer of AHT), holds a 4.2% passive equity interest in Pinnacle Laboratory Services Inc. This equity interest was not disclosed in AHT's conflict-of-interest records prior to the Grayson Whitaker gap assessment. Referral Volume. AHT clinics located in Rhode Island and south

II. FACTUAL BACKGROUND The following factual background is based on Calderwood & Harkness LLP's review of documents provided by AHT, interviews with AHT management and compliance personnel, the Grayson Whitaker gap assessment report, publicly available information, and other materials gathered during the course of this engagement. All factual statements herein are based on information available as of the date of this

III. APPLICABLE LEGAL FRAMEWORK A. Federal Anti-Kickback Statute (42 U.S.C. § 1320a-7b(b)) The Federal Anti-Kickback Statute, codified at 42 U.S.C. § 1320a-7b(b), prohibits any person from knowingly and willfully soliciting, receiving, offering, or paying any remuneration (including any kickback, bribe, or rebate), directly or indirectly, overtly or covertly, in cash or in kind, in exchange for, or to induce, the ref

IV. ANALYSIS — ISSUE 1: NO-COST ELECTRONIC LABORATORY INTERFACE A. Characterization of the Arrangement The threshold question for both AKS and Stark Law analysis is whether the provision of the LabLink Interface at zero cost constitutes "remuneration." Under both statutes, remuneration is defined broadly to include transfers of anything of value, directly or indirectly, overtly or covertly, in cash or in kind. The La

1. Prima Facie Case The elements of a potential AKS violation are present. Pinnacle provides an item of value — the LabLink Interface, with an estimated FMV of $120,000 per year — to AHT, an entity whose physicians refer clinical laboratory services to Pinnacle. In FY2022, AHT physicians referred approximately $1.65 million in outpatient laboratory services to Pinnacle. Under the "one-purpose test" articulated in Uni

2. Safe Harbor Analysis — Personal Services (42 C.F.R. § 1001.952(d)) The personal services and management contracts safe harbor does not apply to the LabLink Interface arrangement. The provision of the interface is not structured as a personal services contract. The PLA does not contain a separate, written agreement specifying the LabLink Interface as a service with aggregate compensation set in advance at fair mark

3. Safe Harbor Analysis — Electronic Health Records (42 C.F.R. § 1001.952(y)) The EHR items and services safe harbor requires careful analysis. This safe harbor was designed to encourage the adoption and use of electronic health records technology by permitting certain donations of EHR software and related services. However, the safe harbor was not designed to protect laboratory-specific ordering interfaces that func

4. Other Safe Harbors No other AKS safe harbor appears applicable to the no-cost provision of the LabLink Interface. The arrangement does not qualify as a discount, a warranty, or a bona fide employment relationship. The waiver-of-coinsurance safe harbor is not relevant. The group purchasing organization safe harbor does not apply. The arrangement does not fall within the scope of the managed care safe harbor or the

5. Overall AKS Conclusion on Issue 1 The no-cost provision of the LabLink Interface presents a significant AKS violation risk. The arrangement involves the transfer of substantial value ($120,000 per year) from a laboratory that receives referrals to the entity whose physicians make those referrals, in connection with a preferred laboratory designation that generates $1.65 million in annual referral volume. No safe h

1. Compensation Arrangement Analysis Under the Stark Law, the no-cost provision of the LabLink Interface constitutes remuneration from Pinnacle to AHT, creating a compensation arrangement between a DHS entity (Pinnacle, which provides clinical laboratory services) and an entity whose physicians make referrals for DHS. The existence of this compensation arrangement triggers the Stark Law prohibition unless an applicab

2. Non-Monetary Compensation Exception (42 C.F.R. § 411.357(k)) The non-monetary compensation exception permits an entity that furnishes DHS to provide non-monetary compensation to a referring physician, provided that the aggregate value of the non-monetary compensation does not exceed the annual threshold established by CMS. For calendar year 2023, the threshold is $459 per physician per calendar year. The LabLink I

3. Fair Market Value Exception (42 C.F.R. § 411.357(l)) The fair market value exception requires that compensation under the arrangement be consistent with fair market value for identifiable items or services actually provided. The LabLink Interface is provided at zero cost — not at FMV. Because the compensation (zero) is not consistent with the FMV of the services provided (approximately $120,000 per year), the fair

4. Indirect Compensation Arrangement Exception (42 C.F.R. § 411.357(p)) If the LabLink Interface is characterized as compensation flowing from Pinnacle to AHT (rather than directly to individual physicians), the referring physicians' relationship with Pinnacle may be analyzed as an indirect compensation arrangement under 42 C.F.R. § 411.354(c). Under this analysis, there is an unbroken chain of financial relationship

5. Overall Stark Law Conclusion on Issue 1 The no-cost provision of the LabLink Interface likely constitutes a non-excepted compensation arrangement that renders referrals from AHT physicians to Pinnacle for DHS non-compliant under the Stark Law. No exception available under current regulations appears to protect the arrangement in its present form. If this analysis is correct, every referral from an AHT physician to

V. ANALYSIS — ISSUE 2: CME SPONSORSHIP A. Characterization of the Arrangement Pinnacle sponsored four CME events for AHT physicians in FY2022, with a total sponsorship value of $86,000. The sponsorship covered the full cost of the events, including speaker fees, venue rental, catering, and CME credit administration. The events were attended by AHT physicians who practice at clinics subject to the PLA and who are sour

1. Remuneration. The CME sponsorship constitutes remuneration under the AKS. By funding the entirety of the CME events, Pinnacle provides something of value — educational programming, meals, and CME credits — to AHT physicians who are in a position to refer, and who do in fact refer, laboratory services to Pinnacle. The value of the remuneration is substantial: $86,000 in aggregate across four events in a single fisc

2. One-Purpose Test Even if the primary purpose of the CME events is educational — and there is no reason to doubt that the events provided genuine educational content to attending physicians — the AKS requires only that one purpose of the remuneration be to induce or reward referrals. The factual circumstances surrounding the CME sponsorship support an inference that at least one purpose of the sponsorship is to mai

3. OIG Guidance The OIG has repeatedly expressed concern about industry-sponsored CME, particularly when the sponsor has a financial interest in the referral decisions of the attending physicians. In its Special Fraud Alert on Speaker Programs (November 2020), the OIG highlighted the risk that industry-sponsored educational events may serve as vehicles for remuneration that induces referrals, even when the events hav

4. Safe Harbor Analysis No specific CME safe harbor exists under the AKS. The personal services and management contracts safe harbor (42 C.F.R. § 1001.952(d)) does not apply because the CME sponsorship is not structured as a personal services contract. Pinnacle is not providing services under a written agreement with specified services, a term of at least one year, and aggregate compensation set in advance at FMV. Ra

5. Risk Factors Several factors elevate the AKS risk associated with the CME sponsorship: (a) Direct sponsorship by a referral recipient. Pinnacle directly funds events attended by physicians who refer to it, creating a clear nexus between the remuneration and the referral relationship. (b) Events held at AHT locations. The use of AHT clinic locations as event venues reinforces the perception that the CME events are